REC Interventional Cardiology最新文献

{"title":"[[Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis]].","authors":"Lucio Padilla, Jorge Tello, Pablo Lamelas","doi":"10.24875/RECIC.M25000505","DOIUrl":"10.24875/RECIC.M25000505","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 2","pages":"130-131"},"PeriodicalIF":1.2,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Projection selection and rapid atrial pacing improves early outcomes after self-expanding transcatheter aortic valves]].","authors":"María Tamargo, Enrique Gutiérrez, Jorge García Carreño, María Eugenia Vázquez Álvarez, Ricardo Sanz-Ruiz, Mike Huanca, Erika Ludeña, Javier Soriano, Jaime Elízaga, Francisco Fernández-Avilés, Javier Bermejo","doi":"10.24875/RECIC.M24000497","DOIUrl":"10.24875/RECIC.M24000497","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Because of the potential need for permanent pacemaker implantation, patients are frequently monitored for days after transcatheter aortic valve implantation (TAVI), particularly when using self-expanding valves. We sought to determine whether the appearance and management of conduction disturbances after TAVI can be improved by combining the cusp overlap projection (COP) and a rapid atrial pacing (RAP) protocol to detect the need for pacemaker implantation.</p><p><strong>Methods: </strong>We consecutively studied a total of 273 patients who underwent TAVI with self-expanding valves from 2018 through 2022 (134 undergoing standard implantations and 139 COP + RAP). Assessment included the 90-day follow-up.</p><p><strong>Results: </strong>Complete heart block was reported in 25.4% and 14.4% in the standard-of-care and COP + RAP group, with a marked decrease in transient atrioventricular block (12.8% vs 2.9%, respectively; <i>P</i> = .007). The absence of the Wenckebach phenomenon during RAP had a negative predictive value of 97% (95%CI, 91-99) for pacemaker implantation at the follow-up, which significantly decreased the need for 24-hour temporary pacemaker monitoring in the COP + RAP group (91.8% vs 28.1%; <i>P</i> < .0001) and the median [IQR] length of stay (5.0 [4-8] days vs 2.0 [1-4] days; <i>P</i> < .0001). At the 90-day follow-up, COP + RAP reduced pacemaker implantation (OR, 0.48; 95%CI, 0.24-0.92; <i>P</i> = .031), as well as the risk of infection-related readmissions significantly (OR, 0.35; 95%CI, 0.12-0.89; <i>P</i> = .036).</p><p><strong>Conclusions: </strong>The combination of COP + RAP during self-expanding TAVI improves postoperative screening for conduction disturbances, thus reducing the need for cardiac rhythm monitoring, and the length stay. The COP + RAP strategy improves the short-term clinical outcomes of self-expanding TAVI due to fewer infection-related readmissions.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 2","pages":"82-90"},"PeriodicalIF":1.2,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[The ultrathin-strut everolimus-eluting stent in a real-world population: the Everythin multicenter registry]].","authors":"Juan Casanova-Sandoval, Gema Miñana-Escrivà, Eduard Bosch-Peligero, Juan Francisco Muñoz-Camacho, Diego Fernández-Rodríguez, Kristian Rivera, Agustín Fernández-Cisnal, Daniel Valcárcel-Paz, Marcos García-Guimarães","doi":"10.24875/RECIC.M24000484","DOIUrl":"10.24875/RECIC.M24000484","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Ultrathin-strut stents (UTS) represent a significant advancement in percutaneous coronary intervention. This study aimed to evaluate the safety and short- to mid-term outcomes of stenting with the thinnest struts on the market (50 µm) using a biodegradable everolimus-eluting polymer (Evermine 50) in real-world patients with coronary artery disease.</p><p><strong>Methods: </strong>A single-arm, multicenter, prospective study was conducted in real-world patients. A total of 161 patients with de novo lesions who received at least 1 UTS stent were enrolled. The primary safety endpoint was the occurrence of major adverse cardiovascular events, defined as cardiac death, target-vessel myocardial infarction, or the need for revascularization of the target lesion at 12 months. The incidence of stent thrombosis at 12 months was also analyzed.</p><p><strong>Results: </strong>The study included 161 patients with a mean age of 64 ± 14 years; 79% were male, 34% had diabetes, and 66% had hypertension. The most common indication for intervention was non-ST-segment elevation myocardial infarction (42%), followed by ST-segment elevation myocardial infarction (22%). The procedural success rate was 100%. At 12 months of follow-up, the incidence of MACE was 2.5%, and the definite stent thrombosis rate was 1.3%.</p><p><strong>Conclusions: </strong>The use of the 50 µm UTS stent with a biodegradable everolimus-eluting polymer demonstrated a favorable safety profile and good clinical outcomes in unselected patients at 1 year of follow-up.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"23-28"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Plaque modification techniques in patients with CHD undergoing TAVI: the experience of our center]].","authors":"Alicia Prieto-Lobato, Juan Carlos Betancourt Aldana-Villaroel, Beatriz Vaquerizo, Héctor Cubero-Gallego, Xavier Armario, Helena Tizón-Marcos","doi":"10.24875/RECIC.M24000488","DOIUrl":"10.24875/RECIC.M24000488","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"60-63"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Are we ripe for preventive percutaneous coronary interventions?]].","authors":"Elvin Kedhi","doi":"10.24875/RECIC.M24000483","DOIUrl":"10.24875/RECIC.M24000483","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"3-5"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Use of a multistate model in survival predictions in cardiology studies]].","authors":"Natalia Montoya, Alicia Quirós, José M de la Torre-Hernández, José L Ferreiro, Armando Pérez de Prado","doi":"10.24875/RECIC.M24000489","DOIUrl":"10.24875/RECIC.M24000489","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Multistate models have proven to be effective tools in survival analyses. We propose modeling disease progression in interventional cardiology studies using a multistate model.</p><p><strong>Methods: </strong>The model was fitted to the PACO-PCI database including a total of 1057 elderly patients with atrial fibrillation revascularized with drug-eluting stents to assess the efficacy profile and prognosis of different antithrombotic therapies. The model defines a total of 4 states: treatment, myocardial infarction and/or revascularization, bleeding, and death, with significant factors for each transition, and was compared using a multivariate Cox model.</p><p><strong>Results: </strong>Survival factors common to both analyses were the PreciseDAPT and HAS-BLED scales, anemia, diabetes mellitus, chronic kidney disease, number of vessels treated, and left ventricular function. The multistate model also shows that after a new hemorrhage the probability of myocardial infarction and/or revascularization is influenced by the treatment of left main coronary artery disease and the transition to death from previous coronary artery bypass graft. Compared with Cox models, multistate models allow us to tell which transition in the model is influenced by each predictor.</p><p><strong>Conclusions: </strong>The results illustrate the additional advantages of multistate models in survival analyses through individual predictions for the patients based on their clinical characteristics and disease progression.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"44-50"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Incidence and predictors of radial artery occlusion following transradial coronary procedures]].","authors":"Mohamed Sofiane Lounes, Abdelouahed Meftah, Ali Bedjaoui, Chamseddine Belhadi, Karima Allal, Hacene Boulaam, Adel Sayah, Ilies Hafidi, Elhadi Tebache, Abdelhakim Allali, Salim Benkhedda","doi":"10.24875/RECIC.M24000479","DOIUrl":"10.24875/RECIC.M24000479","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>The use of transradial access for percutaneous coronary procedures has increased due to its advantages over the femoral approach. However, this benefit comes at the expense of a higher rate of radial artery occlusion (RAO). Our objective was to assess the incidence and predictors of RAO following transradial catheterization. Additionally, we studied anatomic variations of the radial artery (RA).</p><p><strong>Methods: </strong>This prospective study enrolled 427 patients who underwent coronary angiography or angioplasty via transradial access. The forearm arteries were evaluated by ultrasound. If RAO was present, follow-up ultrasound examinations were performed at 1 and 3 months postprocedure.</p><p><strong>Results: </strong>Our study population included 288 men (67.4%) and 139 women (32.6%). The mean age was 61.9 ± 11.1 years. RAO occurred in 48 patients (11.24%), and spontaneous recanalization was observed within 3 months in 15 patients (32.6%). On multivariate analysis, independent predictors of RAO were younger age (OR, 0.642; 95%CI, 0.480-0.858; P = .031), low periprocedural systolic blood pressure (OR, 0.598; 95%CI, 0.415-0.862; P = .007), a small radial diameter (OR, 0.371; 95%CI, 0.323-0.618; P = .031), insufficient anticoagulation (OR, 0.287; 95%CI, 0.163-0.505; P < .001), occlusive hemostasis (OR, 0.128; 95%CI, 0.047-0.353; P < .001), and long duration of hemostasis. The overall incidence of RA anatomic variations was 14.8% (n = 63). Among these, 40 patients (63.5%) had a high radial origin, 18 (28.6%) had extreme RA tortuosity, and 5 (7.9%) had a complete radioulnar loop.</p><p><strong>Conclusions: </strong>The main modifiable predictors of RAO are insufficient heparinization and occlusive hemostasis. Preventive strategies should focus primarily on these 2 predictive factors to reduce the risk of RAO.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"15-22"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Drug-coated balloons across different scenarios. Long-term single center experience]].","authors":"David Neves, Miguel Carias, Sílvia Alminhas, Renato Fernandes, Lino Patrício","doi":"10.24875/RECIC.M24000493","DOIUrl":"10.24875/RECIC.M24000493","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 2","pages":"119-121"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[Percutaneous treatment of the left main coronary artery in older adults. Impact of frailty on mid-term results]].","authors":"Ignacio Gallo, Francisco Hidalgo, Rafael González-Manzanares, Marcos Alvarado, Jorge Perea, Javier Suárez de Lezo, Miguel Romero, Soledad Ojeda, Manuel Pan","doi":"10.24875/RECIC.M24000471","DOIUrl":"10.24875/RECIC.M24000471","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>In elderly and frail patients, there is limited evidence on the therapeutic management of left main coronary artery (LM) disease. The objective of this study was to evaluate mid-term clinical outcomes in older adults undergoing percutaneous coronary intervention (PCI) of LM.</p><p><strong>Methods: </strong>We conducted a retrospective study including all older patients (≥ 75 years) undergoing LM-PCI at a high-volume center between 2017 and 2021. The primary endpoint was a composite of major adverse cardiovascular events (MACE). Patients were grouped according to the presence of frailty based on the FRAIL scale. Inverse probability of treatment weighting was used to account for clinical differences between the 2 groups.</p><p><strong>Results: </strong>A total of 140 patients were included in the study (median age 80 [78-84]; 36% women). Of them, 49% met the criteria for frailty. After a median follow-up of 19 [5-35] months, 40 MACE (29%) were recorded. The all-cause death rate was 32%. There were no differences in the risk of MACE between frailty groups, but patients with frailty had an increased risk of all-cause mortality (HR_adj, 1.95 [1.02-3.75]; P = .046).</p><p><strong>Conclusions: </strong>LM-PCI in older adults with multiple associated comorbidities could be considered a feasible option in this special population. The rate of MACE at follow-up was acceptable. Frailty was associated with a worse prognosis in terms of all-cause mortality at follow-up.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"6-14"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[[TAVI for aortic regurgitation using dedicated devices. A systematic review]].","authors":"Ahmed Hassan, Mahmoud Abdelshafy, Rehab Adel Diab, Hendrik Wienemann, Matti Adam, Santiago García, Marwan Saad, Mohammad Abdelghani","doi":"10.24875/RECIC.M24000480","DOIUrl":"10.24875/RECIC.M24000480","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Transcatheter aortic valve implantation (TAVI) for pure aortic regurgitation is challenging due to inadequate device anchoring and increased risks of device embolization and paravalvular regurgitation (PVR). This study aimed to review the safety and efficacy of TAVI for aortic regurgitation with devices specifically designed for this indication.</p><p><strong>Methods: </strong>A comprehensive search of PubMed, Web of Science, Cochrane Library, and major conference archives up to April 2024 identified 143 unique results based on predefined criteria.</p><p><strong>Results: </strong>Fifteen studies (n = 788 patients) were included, with J-Valve used in 357 patients and JenaValve in 431. Men represented 51% of the cohort, with a mean age of 74.7 ± 8.8 years and an STS-PROM score of 5.8 ± 4.9%. Transapical and transfemoral access routes were used in 62.7% and 37.3% of patients, respectively. Overall, procedural success was achieved in 95.9% of cases; surgical conversion was required in 1.8%, device migration/embolization occurred in 3.2%, and a second valve (in-valve) was required in 2.0% of patients. At 30 days, 95.5% of patients were alive, and device success was reported in 93.3% of cases. Mild PVR was observed in 18.0% of patients, moderate-to-severe PVR in 1.7%, and permanent pacemaker implantation (PPI) was required in 13.0%. In studies focusing on transfemoral procedures (all using JenaValve), the pooled estimates showed a procedural success rate of 97.8% (95%CI, 94.4-100), device success of 97.0% (95%CI, 94.8-99.2), 30-day mortality of 1.96% (95%CI, 0.20-3.72), moderate-to-severe PVR of 0.47% (95%CI, 0.00-1.47), and PPI requirement of 18.7% (95%CI, 13.9-23.4).</p><p><strong>Conclusions: </strong>This systematic review of relatively small observational studies demonstrates the safety and favorable early outcomes of TAVI using J-Valve and JenaValve in patients with pure aortic regurgitation, especially when the transfemoral approach is used. Nevertheless, the need for PPI remains frequent.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 1","pages":"29-43"},"PeriodicalIF":1.2,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}